Takeda · 2 weeks ago
Senior Director, Global Program Leader - Oncology, Solid Tumors
Boston, MA
Full-time
Hybrid
Director/Executive
$208K/yr - $327K/yr
10+ years expTakeda is a patient-focused, innovation-driven pharmaceutical company that empowers its employees to realize their potential through life-changing work. The Senior Director, Global Program Leader - Oncology, Solid Tumors is responsible for leading global programs from discovery to commercialization, ensuring regulatory approval and global patient access while managing cross-functional teams and budgets.
BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Responsibilities
The GPL defines the asset strategy and leads all development and LCM projects associated with an asset from discovery to the marketplace
GPLs must be experienced, versatile and strong enterprise leaders
Committed to simultaneously driving regulatory approval as well as launch and global patient access
Ability to partner with all functions to drive, deliver and maximize asset value
Effective in communicating, decision making and committing to areas of joint decision making
For a given asset, responsible for an overarching global program strategy and execution
The GPL leads all research, development, commercial and LCM activities associated with an asset from discovery to the marketplace with full accountability
Leads the Asset Strategy together with the commercial leader in the context of unmet medical need, competitive landscape, and key TPP attributes required to bring the product to market and to ensure global access for patients in context of Takeda’s values Patient-Trust-Reputation-Business
For a given asset, the GPL is the single leader of a cross functional team, the Global Program Team (GPT)
The GPL ensures through the functional sub-teams leaders and their teams all project deliverables achieve defined project scope & objectives, budget and timelines with full functional support, keeping in mind value maximization and strong sense of the time/quality balance
Provides matrix management, strategic and tactical leadership to GPT members who are responsible for leading the key deliverables of the functional sub-teams for a given asset
Accountable with the responsible Global Program Manager for activities operating budgets within the global program; leads budget setting in collaboration with functions and manages variance to budget ensuring overall Takeda financial objectives are met
Reports on program progress, issues, related updates, new requests for decision related to strategic scope or budget increase (new recommendations, change or buy-up) or timelines change and risks to TA Unit or and Takeda executive management governance committees as per company process
Manages several assets, depending on the size and stage or the programs
Showcases the GPL leadership skills and Enterprise GPT operating model functioning and deliverables through all job attributes defined at Takeda
May lead key business initiatives Evaluates new opportunities and provides overall support for feasibility studies on potential global programs
Leads the Global Program in setting program vision, strategy, goals, priorities and long-term plans and schedules
Aligns cross-functional, cross-divisional project goals with Takeda business needs and strategies
Works closely with the GPM in order to provide strategic, process, and operational leadership to multiple GPTs and Takeda functions in the successful delivery of projects from discovery to commercialization and LCM activities
Could manage 3-5 projects for across all phases of development including innovative early POM/POC in novel mechanisms with less-defined regulatory pathways through large-scale Phase III/submission projects and global launch projects
Links GPT cross-functional sub-teams, such as the Clinical Subteam, Commercial Subteam, Pharmaceutical Sciences (CMC) Subteam, etc. to the GPT through function-based subteam leaders to execute according to the Enterprise GPT Playbook, align and ensure transparency of all program-related activities
Provides leadership and support to TA Leaders and Sub-team leaders to set the vision and direction for the Therapeutic Area and prioritizes all aspects of projects within a global program
Reports on progress of projects, plans/plan changes, critical path, possible scenario and issues/risks/impact to TA Unit and Takeda executive management through internal or external reviews of global programs
Leads key business initiatives for example, evaluates new opportunities (i.e. in-licensing candidates, impact of change in market conditions or availability of new project data in disease areas where Takeda has little or no previous experience) and provides overall support for feasibility studies on potential global programs-non exhaustive list
Accountable with the responsible GPM for project operating budgets within the global program; monitor and control expenditures; manages variance between budgeted and actual expenditures of time, dollars, and personnel while meeting overall Takeda financial objectives
Manages internal and external resources (people, information, technologies, time, and capital); allocates project resources appropriately, given division, function and individual goals and objectives to align with business imperatives
Proactively and regularly identifies/monitor project risks before they transform into issues and develops contingency plans; communicates timely and proactively project-related issues to senior executive management and manages issues to resolution
Consults with TAU, Franchise Leadership and Portfolio Office to deliver accurate and timely project status and deliverable information to enable the organization to focus on key priorities and enhance its ability to deliver work (e.g. studies/projects) on-time and on-budget (including proficient use of systems to improve reporting or access to data)
Proactively responds to the dynamics of a changing marketplace; directs adjustments in functional or cross-divisional plans in response to changes in strategic direction
Change management agent for the GPT
Contributes to the creation and maintenance of systems/databases for the purpose of tracking key performance indicators (KPIs), trending, learning, and improving decisions regarding program performance and continuance
Provides matrix management, strategic and tactical leadership to GPT members who are responsible for leading the key deliverables or functional sub-teams within individual projects
Sub-team leads are primarily accountable to the GPL
Stakeholder management is also an expectation as a result of the highly matrixed work environment
Qualification
Required
Advanced scientific degree (MD, or PhD, or PharmD) or MBA
Minimum of 10 years related experience in the pharmaceutical industry, with working knowledge of research and development and commercial operations
Minimum 8 years interdisciplinary global experience with complex projects including strategy and execution and matrix team management
Preferred
Advanced degree in science or business is desired
Broad business/enterprise orientation is highly preferred
Managed multiple NME global approvals
Project Management Professional certification from PMI desired
Benefits
Short-term and/ or long-term incentives
Medical, dental, vision insurance
401(k) plan and company match
Short-term and long-term disability coverage
Basic life insurance
Tuition reimbursement program
Paid volunteer time off
Company holidays
Well-being benefits
Up to 80 hours of sick time
Up to 120 hours of paid vacation
Company
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
10001+ employees
H1B Sponsorship
Takeda has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (39)
2023 (38)
2022 (34)
2021 (44)
2020 (18)
Funding
Current Stage
Public CompanyTotal Funding
$2.46B2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M
Leadership Team
Christophe Weber
President and CEO
Schuyler Fairfield
Senior Vice President, Global Head of Supply Chain
Recent News
Pharmaceutical Technology
2026-01-11
2026-01-09
Company data provided by crunchbase